| __timestamp | Alpine Immune Sciences, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 84580000 |
| Thursday, January 1, 2015 | 16054000 | 86943000 |
| Friday, January 1, 2016 | 23316000 | 84493000 |
| Sunday, January 1, 2017 | 10626000 | 64988000 |
| Monday, January 1, 2018 | 28970000 | 74951000 |
| Tuesday, January 1, 2019 | 35847000 | 62331000 |
| Wednesday, January 1, 2020 | 27185000 | 28607000 |
| Friday, January 1, 2021 | 58742000 | 32228000 |
| Saturday, January 1, 2022 | 70243000 | 46600000 |
| Sunday, January 1, 2023 | 80904000 | 54886000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and Dynavax Technologies Corporation have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Alpine Immune Sciences increased its R&D expenses by over 560%, peaking in 2023. In contrast, Dynavax Technologies saw a 35% decrease in R&D spending over the same period, with a notable dip in 2020. This divergence highlights Alpine's aggressive push towards innovation, while Dynavax appears to be optimizing its resources. As the biotech industry continues to evolve, these spending patterns may influence each company's future breakthroughs and market positioning. Understanding these trends provides valuable insights into the strategic priorities of these two industry players.
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Research and Development Investment: Genmab A/S vs Alpine Immune Sciences, Inc.
R&D Insights: How Incyte Corporation and Dynavax Technologies Corporation Allocate Funds
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Novavax, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation Allocate Funds